Ophthalmic Pharmacology Practice Questions

Q: Which antiglaucoma drug acts by increasing uveoscleral outflow?

Latanoprost. **Explanation:** The correct answer is **Latanoprost**. To understand why, we must look at how aqueous humor exits the eye. There are two main pathways: the **Trabecular (conventional) pathway** (80-90%) and the **Uveoscleral (unconventional) pathway** (10-20%). **1. Why Latanoprost is correct:** Latanoprost is a **Prostaglandin F2α analogue**. It works by remodeling the extracellular matrix in the ciliary muscle, reducing resistance and significantly increasing **uveoscleral outflow**. Due to their high efficacy and once-daily dosing, PG analogues are the first-line treatment for Primary Open Angle Glaucoma (POAG). **2. Why the other options are incorrect:** * **Apraclonidine:** An alpha-2 agonist. It primarily acts by **decreasing aqueous production** and, to a lesser extent, increasing trabecular outflow. * **Timolol:** A non-selective beta-blocker. It acts solely by **decreasing aqueous production** from the ciliary epithelium. It has no effect on outflow. * **Brinzolamide:** A topical Carbonic Anhydrase Inhibitor (CAI). It reduces the secretion of aqueous humor by inhibiting the enzyme required for bicarbonate production in the ciliary body. **High-Yield Clinical Pearls for NEET-PG:** * **Uveoscleral Outflow:** Increased by Prostaglandins (Latanoprost, Bimatoprost) and Alpha-agonists (Brimonidine). * **Trabecular Outflow:** Increased by Miotics (Pilocarpine) and Rho-kinase inhibitors (Netarsudil). * **Side Effects of Latanoprost:** Increased iris pigmentation (heterochromia), hypertrichosis (thickening of eyelashes), and cystoid macular edema (CME) in aphakic patients. * **Contraindication:** Avoid PG analogues in inflammatory glaucoma (uveitic glaucoma) as they may exacerbate inflammation.

Q: A patient with glaucoma develops blepharoconjunctivitis after instilling an anti-glaucoma medication. Which of the following drugs is most likely responsible for this side effect?

Timolol. **Explanation:** The correct answer is **Timolol**. **Why Timolol is the correct answer:** Timolol, a non-selective beta-blocker, is one of the most common anti-glaucoma medications associated with **allergic contact blepharoconjunctivitis**. This hypersensitivity reaction typically manifests as itching, redness of the conjunctiva, and eczematous changes (scaling and erythema) of the eyelid skin. While the active drug itself can cause this, the preservative **Benzalkonium chloride (BAK)**, frequently found in Timolol formulations, is also a major culprit for ocular surface toxicity and follicular conjunctivitis. **Analysis of Incorrect Options:** * **Latanoprost:** While it can cause conjunctival hyperemia, its hallmark side effects are iris hyperpigmentation, eyelash lengthening (trichomegaly), and periorbitopathy. It is less commonly associated with acute blepharoconjunctivitis compared to beta-blockers. * **Dipivefrine:** This is a prodrug of epinephrine. Its classic side effect is **follicular conjunctivitis** and adrenochrome deposits, but it is rarely used in modern practice due to systemic sympathomimetic effects. * **Pilocarpine:** A miotic agent. Its primary side effects are "brow ache" (due to ciliary muscle contraction), pupillary constriction (miosis), and potential retinal detachment. It does not typically cause blepharoconjunctivitis. **High-Yield Clinical Pearls for NEET-PG:** * **Brimonidine:** Among all glaucoma drugs, Brimonidine (Alpha-2 agonist) has the **highest incidence** of delayed-type hypersensitivity reactions (up to 30%), often presenting as a late-onset follicular conjunctivitis. * **Dorzolamide:** Can cause a bitter taste (dysgeusia) and local stinging. * **Systemic Side Effects of Timolol:** Always remember to screen for asthma or bradycardia, as systemic absorption via the nasolacrimal duct can trigger bronchospasm or heart block. Punctal occlusion after instillation can minimize these risks.

Q: Which of the following topical local anesthetics is commonly used in cataract surgery?

Proparacaine 0.5%. ***Proparacaine 0.5%***- It is an **ester-type** topical anesthetic that provides rapid, short-duration anesthesia essential for preparatory steps (like measuring **intraocular pressure**) and the initiation of cataract surgery. - **Proparacaine** is the highly preferred topical agent in ophthalmology due to its low corneal toxicity and efficacy in anesthetizing the **corneal** and **conjunctival** surfaces. *Bupivacaine 0.5%*- **Bupivacaine** is an **amide-type** anesthetic known for its potent, long-lasting effects, typically utilized for regional or infiltration blocks (e.g., retrobulbar or peribulbar blocks) in the eye, but not standard for topical application alone.- It is less favored than proparacaine for simple topical anesthesia due to potential **corneal epithelial toxicity** if used excessively topically.*Halothane*- **Halothane** is a potent **volatile inhaled general anesthetic** agent used to induce unconsciousness and muscle relaxation during major surgery.- It is not a local anesthetic agent and cannot be used topically to anesthetize the **ocular surface**.*Nitrous Oxide*- **Nitrous oxide** is an **inhalational anesthetic gas** often used for sedation (or as an adjunct to general anesthesia) due to its analgesic properties.- It provides systemic central nervous system effects and is not formulated or used as a **topical local anesthetic** solution for eye surgery.

Q: Which route is most preferred for Endophthalmitis treatment?

Intravitreal antibiotic. ***Intravitreal antibiotic*** - **Intravitreal injection** directly delivers a high concentration of antibiotics into the **vitreous cavity**, which is essential for treating intraocular infections like endophthalmitis. - This route bypasses protective barriers like the **blood-retinal barrier**, ensuring therapeutic drug levels reach the infection site promptly and effectively. *Oral antibiotic* - **Oral antibiotics** have poor penetration into the **vitreous humor** due to the **blood-retinal barrier**, making them generally ineffective as a sole therapy for endophthalmitis. - They may be used as an adjunct in some cases but cannot achieve the high local concentrations needed to resolve severe intraocular infections. *Intravenous antibiotic* - Similar to oral antibiotics, **intravenous antibiotics** struggle to penetrate the **blood-retinal barrier** adequately to achieve therapeutic concentrations in the vitreous humor for endophthalmitis. - While they can be administered in severe cases, they do not provide the direct, high-dose delivery needed to control the infection within the eye as effectively as intravitreal injections. *Topical antibiotic* - **Topical antibiotics** primarily reach the ocular surface and anterior segment of the eye, with very limited penetration into the **vitreous cavity**. - They are generally ineffective for treating endophthalmitis, which is an infection of the inner eye, and are typically reserved for superficial ocular infections.

Q: Drug commonly used in the treatment of iridocyclitis is

Atropine. ***Atropine*** - **Atropine** is a potent **cycloplegic** and **mydriatic** agent, effectively paralyzing the ciliary muscles and dilating the pupil. - In **iridocyclitis (anterior uveitis)**, this action helps to **rest the inflamed iris and ciliary body**, prevent posterior synechiae formation, and reduce pain from ciliary spasm. - Atropine is the **drug of choice** for managing acute iridocyclitis due to its long duration of action (7-14 days). *Phenylephrine* - **Phenylephrine** is primarily a **sympathomimetic** drug that causes **mydriasis** (pupil dilation) but has **minimal cycloplegic** (ciliary muscle paralysis) effect. - While it can dilate the pupil, it does not provide the crucial **ciliary body rest** needed to manage inflammation and prevent synechiae in iridocyclitis. *Pilocarpine* - **Pilocarpine** is a **muscarinic agonist** that causes **miosis** (pupil constriction) and **accommodation**. - It would be **contraindicated** in iridocyclitis as it increases ciliary spasm, worsens pain, and promotes posterior synechiae formation. *Timolol* - **Timolol** is a **beta-blocker** used in the treatment of **glaucoma** to reduce intraocular pressure. - It has **no role** in managing inflammation or preventing complications in iridocyclitis.

Q: Which of the following drugs is not used in treatment of iridocyclitis:

Timolol eye drops. ***Timolol eye drops*** - **Timolol** is a **beta-blocker** used to reduce intraocular pressure in **glaucoma** by decreasing aqueous humor production. - It has **no role in iridocyclitis management** as it does not address inflammation, pain, or pupillary abnormalities, which are the key therapeutic targets. - Timolol is simply not part of the treatment protocol for iridocyclitis. *Pilocarpine eye drops* - **Pilocarpine** is a **miotic** agent that constricts the pupil, but it is **contraindicated** in iridocyclitis (not just "not used"). - While not used therapeutically, it's important to distinguish that pilocarpine is actively harmful (increases inflammation and posterior synechiae risk), whereas timolol is simply not indicated. - In the context of this question asking what is "not used in treatment," timolol is the better answer as it's not part of the standard treatment protocol. *Atropine eye ointment* - **Atropine** is a **cycloplegic and mydriatic** agent that is a **cornerstone of iridocyclitis treatment**. - It dilates the pupil and paralyzes the ciliary muscle to prevent and break **posterior synechiae** and relieve pain from ciliary muscle spasm. - By immobilizing the iris and ciliary body, it reduces inflammation and discomfort. *Steroid eye drops* - **Steroid eye drops** (e.g., prednisolone acetate) are **essential for managing iridocyclitis** as they effectively reduce inflammation within the anterior chamber. - They suppress the immune response causing inflammation, thereby alleviating symptoms like redness, pain, and photophobia. - Topical corticosteroids are the mainstay of anti-inflammatory treatment in anterior uveitis.

Q: Atropine is the drug of choice in –

Iridocyclitis. ***Iridocyclitis*** - Atropine is a **potent cycloplegic and mydriatic agent** often used in iridocyclitis to **relax the ciliary body muscles** and prevent the formation of posterior synechiae. - Its **long-acting effect** helps in reducing pain, inflammation, and preventing complications such as iris bombe by keeping the pupil dilated. *Chorioretinitis* - This condition primarily affects the **choroid and retina**, and while inflammation may be present, systemic or topical **corticosteroids** are typically the primary treatment. - Atropine is not indicated as a primary treatment for the inflammation itself in chorioretinitis, as its main action is on the iris and ciliary body. *Lens induced glaucoma* - The definitive treatment for lens-induced glaucoma, such as **phacomorphic glaucoma** or **phacolytic glaucoma**, is surgical removal of the cataractous lens. - Atropine would cause mydriasis, which can paradoxically worsen some forms of glaucoma by blocking the drainage angle, especially in cases of angle closure [1] [2]. *Closed angle glaucoma* - Atropine, being a mydriatic, would **dilate the pupil** and potentially exacerbate closed-angle glaucoma by further **crowding the anterior chamber angle** and blocking aqueous humor outflow [3]. - The focus in closed-angle glaucoma is to constrict the pupil (with miotics like pilocarpine) and reduce intraocular pressure.

Q: What is the percentage of atropine present in atropine drops?

1%. ***1%*** - Atropine eye drops are commonly formulated as a **1% solution** for ophthalmic use. - This concentration is effective for achieving **cycloplegia** (paralysis of the ciliary muscle) and **mydriasis** (pupil dilation) in clinical settings [2]. *2%* - A **2% concentration** is not the standard formulation for atropine eye drops. - Using a higher concentration than necessary could increase the risk of systemic side effects without providing significant additional therapeutic benefit [1]. *3%* - Atropine eye drops are generally not manufactured or prescribed in a **3% concentration**. - While stronger, such a concentration would be unusual and potentially lead to more pronounced or prolonged effects and adverse reactions. *4%* - A **4% concentration** of atropine eye drops is significantly higher than the standard and is not typically used due to the increased risk of systemic absorption and side effects. - High concentrations increase the likelihood of adverse effects such as **tachycardia**, dry mouth, and blurry vision.

Q: Primary objective of the use of atropine in anterior uveitis

Rest to the ciliary muscle. ***Rest to the ciliary muscle*** - Atropine is a **cycloplegic** agent that paralyzes the **ciliary muscle**, thereby alleviating pain caused by spasms and inflammation in anterior uveitis. - This **cycloplegia** is the primary therapeutic goal, as it reduces **ciliary spasm** and the associated pain. *Helps in preventing posterior synechia formation (secondary effect)* - While atropine's **mydriatic** action (pupil dilation) helps prevent the formation of **posterior synechiae**, this is a beneficial secondary effect and not its primary objective in alleviating symptoms or pain. - The dilation breaks existing synechiae or prevents new ones from forming by moving the iris away from the lens capsule. *Increase blood flow* - Atropine's primary action is anticholinergic, leading to **cycloplegia** and **mydriasis**, not a direct increase in ocular blood flow. - Increased blood flow is not a targeted therapeutic effect of atropine in acute anterior uveitis. *Increase supply of antibody* - Atropine does not directly influence the immune system or increase the supply of antibodies to the inflamed eye. - Its mechanism of action is limited to blocking muscarinic acetylcholine receptors.

Question 1

Which antiglaucoma drug acts by increasing uveoscleral outflow?

Accepted Answer

Latanoprost

Answer

Apraclonidine

Answer

Timolol

Answer

Brinzolamide

Question 2

A patient with glaucoma develops blepharoconjunctivitis after instilling an anti-glaucoma medication. Which of the following drugs is most likely responsible for this side effect?

Accepted Answer

Timolol

Answer

Latanoprost

Answer

Dipyvefrine

Answer

Pilocarpine

Question 3

Which of the following topical local anesthetics is commonly used in cataract surgery?

Accepted Answer

Proparacaine 0.5%

Answer

Bupivacaine 0.5%

Answer

Halothane

Answer

Nitrous Oxide

Question 4

Which route is most preferred for Endophthalmitis treatment?

Accepted Answer

Intravitreal antibiotic

Answer

Oral antibiotic

Answer

Intravenous antibiotic

Answer

Topical antibiotic

Question 5

Drug commonly used in the treatment of iridocyclitis is

Accepted Answer

Atropine

Answer

Phenylephrine

Answer

Pilocarpine

Answer

Timolol

Question 6

1% atropine is given in uveitis to:

Accepted Answer

Cause mydriasis and prevent formation of posterior synechiae

Answer

Cause miosis and prevent formation of posterior synechiae

Answer

Cause mydriasis and prevent formation of anterior synechiae

Answer

Reduce inflammation and relieve pain

Question 7

Which of the following drugs is not used in treatment of iridocyclitis:

Accepted Answer

Timolol eye drops

Answer

Pilocarpine eye drops

Answer

Atropine eye ointment

Answer

Steroid eye drops

Question 8

Atropine is the drug of choice in –

Accepted Answer

Iridocyclitis

Answer

Chorioretinitis

Answer

Lens induced glaucoma

Answer

Closed angle glaucoma

Question 9

What is the percentage of atropine present in atropine drops?

Accepted Answer

1%

Answer

2%

Answer

3%

Answer

4%

Question 10

Primary objective of the use of atropine in anterior uveitis

Accepted Answer

Rest to the ciliary muscle

Answer

Helps in preventing posterior synechia formation

Answer

Increase blood flow

Answer

Increase supply of antibody

Ophthalmic Pharmacology — MCQs

Ophthalmic Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?